ELAN
Elanco Animal Health
NYSE: ELAN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$21.80
-1.58% today
Updated 2026-04-29
Market cap
$10.89B
P/E ratio
—
P/S ratio
2.31x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$9 – $28
Volume
5.1M
Elanco Animal Health (ELAN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$21.80
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$31.06
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.8B | $4.4B | $4.4B | $4.4B | $4.7B | $5.1B | $5.5B | $5.9B | $6.3B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 7.57% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -4.92%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.